Pre-market: ALEUP.PA Europlasma S.A. (EURONEXT) down 91% 20 Jan 2026: key drivers
The ALEUP.PA stock plunged -91.24% in pre-market trade to €0.13, making Europlasma S.A. one of the top losers on EURONEXT on 20 Jan 2026. Trading volume has surged to 497,330 shares versus an average of 234,166, signalling forced selling or a liquidity event. We review price action, financial ratios, technical signals and a model forecast to explain why the move is extreme and what to watch next. Meyka AI’s market tools flag high volatility and large downside risk for short-term traders.
Price action and market context for ALEUP.PA stock
The stock opened at €0.45 and fell to a day low of €0.13, with a previous close of €1.54. That intraday swing produced a one-day change of -91.24%. Volume of 497,330 shows trading intensity of 2.12x average. This outsized move contrasts with the Industrials sector, which is modestly positive year-to-date, underscoring company-specific drivers rather than broad sector stress.
Europlasma’s 52-week range is extreme: a year high of €81.75 and a year low of €0.12, reflecting prior restructuring, low float and episodic spikes. For pre-market traders, bid-ask depth is a key near-term risk.
ALEUP.PA stock: fundamentals, valuation and recent financials
Market capitalisation sits at approximately €349,808.00 with 2,593,092 shares outstanding. Trailing EPS is -88.61, so there is no meaningful P/E multiple. Price to sales is 0.01 and price to book shows negative book value per share of -€0.01, indicating balance sheet stress.
Operating cash flow per share is -0.01, free cash flow per share is -0.01, and the current ratio of 0.77 points to short-term liquidity pressures. These metrics explain why institutional investors treat ALEUP.PA stock as high risk.
Technical signals and trading metrics for ALEUP.PA stock
Momentum and volume indicators confirm selling pressure: RSI is 31.82, MACD histogram is -0.05, ADX is 84.57 indicating a strong trend, and MFI is 12.24 signalling oversold conditions. The average 50-day price is €0.36 and the 200-day average is €10.25, showing long-term decline.
On-chain trading metrics show on-balance volume at -2,260,089.00 and relative volume at 2.12, both consistent with panic selling. Short-term traders should expect wide spreads and erratic fills.
Meyka AI rates ALEUP.PA with a score out of 100 and forecast
Meyka AI rates ALEUP.PA with a score out of 100: 64.96 (Grade: B), suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The internal model balances weak cash flows against possible operational recovery in waste treatment and renewable projects.
Meyka AI’s forecast model projects a monthly price of €0.22 compared with the current price of €0.1349, implying an upside of 63.10%. Forecasts are model-based projections and not guarantees. Use this as one input alongside liquidity and risk checks.
Risks, catalysts and sector backdrop for ALEUP.PA stock
Key company risks include negative equity metrics, persistent operating losses, and thin liquidity. Interest coverage is -8.44, and enterprise value to sales is 0.28, reflecting leverage relative to size. Europlasma operates in Waste Management within Industrials, where major peers show healthier margins and higher PB ratios, so sector tailwinds offer limited offset.
Catalysts that could change sentiment include new contracts for plasma waste treatment, asset disposals, or capital raises. Monitor official company announcements and the next earnings calendar entry.
Price targets and trading scenarios for ALEUP.PA stock
Analyst-style scenario targets: conservative recovery target €0.25 (upside 85.14% vs €0.1349), base case from Meyka model €0.22 (upside 63.10%), and optimistic turnaround target €0.40 (upside 196.46%). All targets assume successful operational improvements and no further dilution.
Given current volatility, traders should size positions small, set tight limits, and prepare for rapid moves. Long-term investors must verify capital structure changes and cash runway before adding exposure.
Final Thoughts
ALEUP.PA stock is the day’s top pre-market loser on EURONEXT, down -91.24% to €0.13 as of 20 Jan 2026. The move is driven by acute liquidity and valuation stress: negative EPS of -88.61, negative book value per share and weak cash flow metrics heighten near-term downside risk. Technical indicators show oversold conditions but strong trend momentum, so rebounds may be short lived without fundamental repair. Meyka AI’s forecast model projects €0.22 monthly, implying 63.10% upside from €0.1349, but this remains a model projection and not a guarantee. For traders we emphasise small position sizing and strict risk controls. For investors considering ALEUP.PA stock as part of a recovery play, demand full disclosure on funding plans, contracts and potential dilution. Use company filings and updates and the listing page for confirmations before acting. Meyka AI provides this as an AI-powered market analysis platform input to your due diligence.
FAQs
Why did ALEUP.PA stock drop so sharply in pre-market?
The sharp pre-market drop reflects liquidity stress, negative earnings history (EPS -88.61) and heavy volume. Company-level news, balance sheet concerns or forced selling likely triggered the move, not broad sector weakness.
What is Meyka AI’s forecast for ALEUP.PA stock?
Meyka AI’s forecast model projects a monthly price of €0.22 versus the current €0.1349, implying roughly 63.10% upside. Forecasts are model-based projections and not guarantees.
Should I trade ALEUP.PA stock after this drop?
Trading is high risk due to thin liquidity and volatile spreads. If trading, use small sizes, limit orders and stop-loss rules. Confirm company announcements and funding plans before exposure.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
